StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Corbus Pharmaceuticals's enterprise value was -$43.26M on Nov 11, 2026, against $40.67M a year earlier. Over the last 5 years it ranged from -$84.39M to $556.48M, with a median of -$318.77K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$43.26M–
2025Dec 31, 2025-$1.95M–
2024Dec 31, 2024-$15.64M-198.8%
2023Dec 29, 2023$15.84M–
2022Dec 30, 2022-$33.05M–
2021Dec 31, 2021-$11.20M-128.9%
2020Dec 31, 2020$38.76M-87.0%
2019Dec 31, 2019$298.30M+7.1%
2018Dec 31, 2018$278.64M-12.9%
2017Dec 29, 2017$319.82M-9.3%
2016Dec 30, 2016$352.63M+621.5%
2015Dec 31, 2015$48.88M-29.8%
2014Dec 31, 2014$69.61M–

More Corbus Pharmaceuticals figures

See a number that looks wrong?